Indeed, treatment of mice bearing PyMT1/GPx2 KD tumors with daily intraperitoneal injection of echinomycin for 21 d following tumor onset substantially reduced mammary tumor growth (Fig. 3G). This evidence concerns the gene GPX2 and breast cancer.